ABSTRACT
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Nicoleta Baxan is first author on ‘Characterization of acute TLR-7 agonist-induced hemorrhagic myocarditis in mice by multi-parametric quantitative cardiac magnetic resonance imaging’, published in DMM. Nicoleta conducted the research described in this article while in Dr Susanne Sattler's lab at Imperial College London, UK. She is now an MR Physics Research Associate in the lab of Prof. Lan Zhao at Biological Imaging Centre, Imperial College London, UK, investigating the development of novel multi-parametric cardiac magnetic resonance (CMR) tissue-mapping techniques to make progress in the diagnosis and treatment of heart diseases.
Nicoleta Baxan
How would you explain the main findings of your paper to non-scientific family and friends?
Immune-mediated damage to the heart may occur as the result of a wide variety of underlying conditions, including infectious disease, exposure to toxins, chemotherapeutic agents, and systemic inflammation due to autoimmune disease. CMR mapping provides unique information of tissue damage in inflammatory disease by tracking subtle changes in myocardium, such as specific disease pathways related to intracellular disturbances of cardiomyocytes (iron deposition); extracellular disturbances in the myocardial interstitium (fibrosis from accumulation of collagen); or both (myocardial edema and cellular infiltrate with increased intracellular and/or extracellular water). In this study, we identified a significant amount of interstitial iron in the hearts of Resiquimod-treated mice, which is most likely the result of hemorrhage, erythrocyte cell death and hemoglobin degradation. We show that chronic anti-heart autoimmunity in the Resiquimod model of systemic lupus erythematosus (SLE) follows acute thrombocytopenia and hemorrhagic myocarditis, and provide a thorough comparison of in vivo CMR parameter measurements with the underlying heart histopathology.
What are the potential implications of these results for your field of research?
Acute myocarditis may trigger an autoimmune reaction against the heart, and it is feasible that severity of hemorrhaging, acute tissue damage and subsequent autoimmunity are correlated. The ability to non-invasively discriminate different processes of tissue damage by using specific magnetic resonance imaging (MRI) metrics based on changes in myocardial parameters T1, T2, T2* will allow insight into the natural history of disease and improve our understanding of the potentially subclinical course of cardiac involvement in systemic inflammation.
“Studying genetically diverse mouse panels instead of a single inbred mouse line may reveal a range of susceptibilities.”
What are the main advantages and drawbacks of the model system you have used as it relates to the disease you are investigating?
Myocardial hemorrhage is not commonly reported in patients with myocarditis. Underlying mechanisms leading to hemorrhage in some myocarditis patients but not in others and implications on survival and subsequent development of inflammatory cardiomyopathies are far from understood. The specific phenotype of hemorrhagic myocarditis has only been studied in Resiquimod-induced systemic inflammation in CFN mice. Considering that myocardial hemorrhaging may be more common than currently appreciated in systemic inflammation of both infectious and autoimmune origin, as well as directly heart-targeted infections, these processes need to be characterized in the corresponding mouse models. Considering that only a small proportion of human patients develop clinically detected hemorrhagic myocarditis, there is likely to be a genetic component to disease susceptibility. Studying genetically diverse mouse panels instead of a single inbred mouse line may reveal a range of susceptibilities.
In acute stage, the mouse model used in this study closely mimics physiological responses to a viral infection due to the stimulation of the TLR-7 pathway. TLR-7 is a pattern-recognition receptor involved in recognition of single-stranded RNA of viral origin, and is thus crucial in host defense against viral infections. Artificial over-activation of this virus defense system may cause the same phenomena as seen in severe complications of viral infection (thrombocytopenia with local hemorrhages at sites of inflammation).
T2* mapping reveals severe cardiac iron deposition in Resiquimod-treated mice. Representative T2* maps of mid-section left ventricle with corresponding Perls Prussian Blue-stained paraffin-embedded heart sections of Resiquimod-treated and control mice showing significant iron deposition. High-magnification images of tissue areas with iron deposition (Perls Prussian Blue) are illustrated to the right.
What has surprised you the most while conducting your research?
I am constantly amazed by the power of multidisciplinary research, and this project is a true example of it. I am an MR physicist by training, and the collaborative nature of this project gave me the opportunity to work with amazing and highly skilled researchers coming from different disciplines (biology, clinical sciences, pharmacology, etc.). Bringing together multiple disciplines brought this paper to light (and most of my research so far), and this almost certainly wouldn't have been done by focusing on a single area.
“I am constantly amazed by the power of multidisciplinary research, and this project is a true example of it.”
Describe what you think is the most significant challenge impacting your research at this time and how will this be addressed over the next 10 years?
The technical challenges of acquiring CMR data synchronized with the cardiac motion combined with the relatively poor pathological specificity of CMR may affect the scan time, the analysis and interpretation of data. New emerging techniques based on artificial intelligence and machine learning approaches are bringing exciting possibilities of faster data acquisition and automated AI-driven quantitative analysis, eliminating many tedious, manual tasks. This will provide enormous opportunities to homogenize data acquisition and computation to better characterize disease by imaging.
“I believe that giving full confidence, responsibility and credit to early-career scientists to conduct their research independently is crucial for their future career.”
What changes do you think could improve the professional lives of early-career scientists?
I am very lucky to have a very supportive PI, giving me the chance to be autonomous in my work and in my projects. I am constantly learning and improving my skills of setting new collaborative projects, presenting my findings and networking. I believe that giving full confidence, responsibility and credit to early-career scientists to conduct their research independently is crucial for their future career.
Footnotes
Nicoleta Baxan's contact details: Biological Imaging Centre, Department of Medicine, Imperial College London, London, UK.
E-mail: n.baxan{at}imperial.ac.uk
- © 2019. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Reference
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Alessandro Bailetti is awarded the DMM Outstanding Paper Prize 2019
The annual prize is awarded to the first author of the paper that is judged by the journal’s editors to be the most outstanding contribution to the journal that year. Alessandro Bailetti's winning paper presents results that indicate a possible connection between E(Pc) and the Tip60 complex, and leukemia. Find out more about Alessandro and read the winning paper.
Find DMM online
We may not be meeting you in person this year, but we’re always here to chat about DMM and The Company of Biologists. Join the conversation over on Twitter, email us or catch Scientific Editor Julija Hmeljak at these upcoming virtual meetings:
MRC Human Genetics Unit (Virtual) Symposium: Aberrant Cell State Transitions in Human Disease
23-24 September
Genomic Imprinting – from Biology to Disease
28 September – 1 October
ZDMS Virtual webinar series
Throughout September – December
Interview - Mohd. Salman
First author Mohd. Salman studies traumatic brain injury. In an interview, he takes us through his latest research in DMM, explaining the potential implications of the findings, and discussing Wistar rats as a model system and life as a early-career researcher.
Call for papers - The RAS Pathway: Diseases, Therapeutics and Beyond
DMM invites you to submit original research for a special issue focused on targeting the RAS pathway. The submission deadline is 1 March 2021. Find out more and showcase your breakthrough research in this special collection.
It’s a time of turmoil for young scientists
“My students are my priority – they are on the brink of their careers.”
Dr Jodie Rummer (ARC Centre of Excellence for Coral Reef Studies at James Cook University) talks about the importance of her role as a supervisor in supporting graduate students and post docs financially, intellectually and emotionally during this period of uncertainty.